Emerging drugs in Europe > GIAS | 2015 | Publicaciones Autor: Papaseit E y otros Revista: Curr Opin Psychiatry Fuente: Pubmed/24840157 Volver a Publicaciones ← Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study Temporal trends in the survival of drug and alcohol abusers according to the primary drug of admission to treatment in Spain →
